Donna Lowe

2.2k total citations
34 papers, 1.7k citations indexed

About

Donna Lowe is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Donna Lowe has authored 34 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 7 papers in Epidemiology. Recurrent topics in Donna Lowe's work include Pituitary Gland Disorders and Treatments (6 papers), Neuroendocrine Tumor Research Advances (4 papers) and Testicular diseases and treatments (3 papers). Donna Lowe is often cited by papers focused on Pituitary Gland Disorders and Treatments (6 papers), Neuroendocrine Tumor Research Advances (4 papers) and Testicular diseases and treatments (3 papers). Donna Lowe collaborates with scholars based in United Kingdom, United States and South Africa. Donna Lowe's co-authors include G. M. Besser, Ashley Grossman, Simran Malik, W. Gregory, M L Slevin, R H Reznek, Richard J. Osborne, Peter Clark, P. F. M. Wrigley and M.O. Savage and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Donna Lowe

34 papers receiving 1.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Donna Lowe 512 506 493 416 381 34 1.7k
Hisashi Tateyama 532 1.0× 318 0.6× 537 1.1× 688 1.7× 232 0.6× 79 2.1k
Masami Sakurai 154 0.3× 458 0.9× 704 1.4× 770 1.9× 266 0.7× 136 2.5k
Valerio Gaetano Vellone 193 0.4× 383 0.8× 406 0.8× 362 0.9× 443 1.2× 136 2.2k
Hangjun Wang 307 0.6× 572 1.1× 351 0.7× 393 0.9× 266 0.7× 47 1.6k
Alaa Afify 164 0.3× 330 0.7× 230 0.5× 250 0.6× 394 1.0× 57 1.5k
J. Solà 169 0.3× 729 1.4× 671 1.4× 268 0.6× 703 1.8× 110 2.4k
João L. Ascensão 138 0.3× 529 1.0× 163 0.3× 173 0.4× 334 0.9× 65 1.8k
William I. Smith 106 0.2× 217 0.4× 176 0.4× 269 0.6× 324 0.9× 38 1.3k
Geneviève Belleannée 151 0.3× 812 1.6× 587 1.2× 278 0.7× 366 1.0× 79 1.7k
James E. Wheeler 232 0.5× 392 0.8× 332 0.7× 145 0.3× 213 0.6× 61 2.2k

Countries citing papers authored by Donna Lowe

Since Specialization
Citations

This map shows the geographic impact of Donna Lowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Lowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Lowe more than expected).

Fields of papers citing papers by Donna Lowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Lowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Lowe. The network helps show where Donna Lowe may publish in the future.

Co-authorship network of co-authors of Donna Lowe

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Lowe. A scholar is included among the top collaborators of Donna Lowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Lowe. Donna Lowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hampton, Naomi, Margaret Rees, Donna Lowe, et al.. (2005). Levonorgestrel intrauterine system (LNG-IUS) with conjugated oral equine estrogen: a successful regimen for HRT in perimenopausal women. Human Reproduction. 20(9). 2653–2660. 52 indexed citations
2.
Cascarini, Luke & Donna Lowe. (2004). Surviving a viva: a guide for candidates. Journal of the Royal Society of Medicine. 97(10). 498–500. 2 indexed citations
3.
Janmohamed, Salim, Ashley Grossman, Kelly Metcalfe, et al.. (2002). Suprasellar germ cell tumours: specific problems and the evolution of optimal management with a combined chemoradiotherapy regimen. Clinical Endocrinology. 57(4). 487–500. 36 indexed citations
4.
Drake, William M, L. A. Perry, Charles Hinds, et al.. (1998). Emergency and Prolonged Use of Intravenous Etomidate to Control Hypercortisolemia in a Patient with Cushing’s Syndrome and Peritonitis. The Journal of Clinical Endocrinology & Metabolism. 83(10). 3542–3544. 78 indexed citations
5.
Jenkins, Paul J., M A Satta, Marcus Simmgen, et al.. (1997). Metastatic parathyroid carcinoma in the MEN2A syndrome. Clinical Endocrinology. 47(6). 747–751. 54 indexed citations
6.
Drake, William, P Jenkins, Rachel R. Phillips, et al.. (1997). Intracardiac metastases from neuroendocrine tumours. Clinical Endocrinology. 46(4). 517–522. 17 indexed citations
7.
8.
Jenkins, P, Shern L. Chew, Donna Lowe, et al.. (1995). Lymphocytic hypophysitis: unusual features of a rare disorder. Clinical Endocrinology. 42(5). 529–534. 34 indexed citations
9.
Jenkins, Paul J., et al.. (1994). Adrenocorticotrophin‐independent unilateral macronodular adrenal hyperplasia occurring with myelolipoma: an unusual cause of Cushing's syndrome. Clinical Endocrinology. 41(6). 827–830. 19 indexed citations
10.
Trainer, Peter, J. Verhelst, Trevor A. Howlett, et al.. (1993). Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successfuI treatment. Clinical Endocrinology. 38(1). 73–78. 224 indexed citations
11.
Neven, Patrick, J. H. Shepherd, & Donna Lowe. (1993). Tamoxifen and the gynaecologist. BJOG An International Journal of Obstetrics & Gynaecology. 100(10). 893–897. 16 indexed citations
12.
Grossman, Ashley, J. V. Anderson, E. Ur, et al.. (1993). Malignant prolactinoma with extracranial metastases: a report of three cases. Clinical Endocrinology. 38(4). 411–419. 44 indexed citations
13.
Granowska, M., K. E. Britton, S J Mather, et al.. (1993). Radioimmunoscintigraphy with technetium-99m-labelled monoclonal antibody, SM3, in gynaecological cancer. European Journal of Nuclear Medicine and Molecular Imaging. 20(6). 483–9. 3 indexed citations
14.
Lowe, Donna. (1991). Set a multiple choice question (MCQ) examination.. BMJ. 302(6779). 780–782. 18 indexed citations
15.
Anderson, M. C., Christopher L. Brown, C. H. Buckley, et al.. (1991). Current views on cervical intraepithelial neoplasia.. Journal of Clinical Pathology. 44(12). 969–978. 64 indexed citations
16.
Cunnah, David, Les Perry, David Grant, et al.. (1989). BILATERAL TESTICULAR TUMOURS IN CONGENITAL ADRENAL HYPERPLASIA: A CONTINUING DIAGNOSTIC AND THERAPEUTIC DILEMMA. Clinical Endocrinology. 30(2). 141–147. 43 indexed citations
17.
Slevin, M L, Peter Clark, Simran Malik, et al.. (1989). A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer.. Journal of Clinical Oncology. 7(9). 1333–1340. 392 indexed citations
18.
Budarf, Marcia L., Beverly S. Emanuel, T. Mohandas, David V. Goeddel, & Donna Lowe. (1989). Human differentiation-stimulating factor (leukemia inhibitory factor, human interleukin DA) gene maps distal to the Ewing sarcoma breakpoint on 22q. Cytogenetic and Genome Research. 52(1-2). 19–22. 26 indexed citations
19.
Lowe, Donna. (1988). Carcinoma of the cervix with massive eosinophilia. BJOG An International Journal of Obstetrics & Gynaecology. 95(4). 393–401. 27 indexed citations
20.
Harris, Philip E., L. A. Perry, T. Chard, et al.. (1988). IMMUNOREACTIVE HUMAN CHORIONIC GONADOTROPHIN FROM THE CYST FLUID AND CSF OF PATIENTS WITH CRANIOPHARYNGIOMA. Clinical Endocrinology. 29(5). 503–508. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hisashi Tateyama Breakdown of academic impact, for papers by Masami Sakurai Breakdown of academic impact, for papers by Valerio Gaetano Vellone Breakdown of academic impact, for papers by Hangjun Wang Breakdown of academic impact, for papers by Alaa Afify Breakdown of academic impact, for papers by J. Solà Breakdown of academic impact, for papers by João L. Ascensão Breakdown of academic impact, for papers by William I. Smith Breakdown of academic impact, for papers by Geneviève Belleannée Breakdown of academic impact, for papers by James E. Wheeler
Rankless by CCL
2026